222 related articles for article (PubMed ID: 21709213)
1. Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy.
Yao J; Wu X; Zhuang G; Kasman IM; Vogt T; Phan V; Shibuya M; Ferrara N; Bais C
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11590-5. PubMed ID: 21709213
[TBL] [Abstract][Full Text] [Related]
2. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
[TBL] [Abstract][Full Text] [Related]
3. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
5. PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.
Incio J; Tam J; Rahbari NN; Suboj P; McManus DT; Chin SM; Vardam TD; Batista A; Babykutty S; Jung K; Khachatryan A; Hato T; Ligibel JA; Krop IE; Puchner SB; Schlett CL; Hoffmman U; Ancukiewicz M; Shibuya M; Carmeliet P; Soares R; Duda DG; Jain RK; Fukumura D
Clin Cancer Res; 2016 Jun; 22(12):2993-3004. PubMed ID: 26861455
[TBL] [Abstract][Full Text] [Related]
6. VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Schultze A; Ben Batalla I; Riethdorf S; Bubenheim M; Yekebas E; Erbersdobler A; Reichelt U; Effenberger KE; Schmidt T; Izbicki JR; Bokemeyer C; Pantel K; Fiedler W; Loges S
Clin Exp Metastasis; 2012 Dec; 29(8):879-87. PubMed ID: 22484977
[TBL] [Abstract][Full Text] [Related]
7. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
[TBL] [Abstract][Full Text] [Related]
9. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
[TBL] [Abstract][Full Text] [Related]
10. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
[TBL] [Abstract][Full Text] [Related]
12. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts.
Taylor AP; Goldenberg DM
Mol Cancer Ther; 2007 Feb; 6(2):524-31. PubMed ID: 17308051
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
[TBL] [Abstract][Full Text] [Related]
14. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
[TBL] [Abstract][Full Text] [Related]
15. Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas.
Jiang H; Wu X; Wang H; Huang C; Zhang L
Cell Physiol Biochem; 2015; 36(3):930-6. PubMed ID: 26088746
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
[TBL] [Abstract][Full Text] [Related]
17. Interaction of mesenchymal stem cells with fibroblast-like synoviocytes via cadherin-11 promotes angiogenesis by enhanced secretion of placental growth factor.
Park SJ; Kim KJ; Kim WU; Cho CS
J Immunol; 2014 Apr; 192(7):3003-10. PubMed ID: 24574497
[TBL] [Abstract][Full Text] [Related]
18. Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.
Hwang JE; Lee JH; Park MR; Kim DE; Bae WK; Shim HJ; Cho SH; Chung IJ
Yonsei Med J; 2013 Mar; 54(2):374-80. PubMed ID: 23364970
[TBL] [Abstract][Full Text] [Related]
19. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.
Schneider K; Weyerbrock A; Doostkam S; Plate K; Machein MR
J Neurooncol; 2015 Jan; 121(2):269-78. PubMed ID: 25370707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
